Journal list menu
Export Citations
Download PDFs
Gynecological Tumor
Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis
- First Published: 10 February 2023
Radioimmunotherapy-induced intratumoral changes in cervical squamous cell carcinoma at single-cell resolution
- First Published: 27 July 2022
The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
- First Published: 02 March 2022
Age-specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross-sectional study
- First Published: 10 February 2022
Programmed death ligand-1 regulates angiogenesis and metastasis by participating in the c-JUN/VEGFR2 signaling axis in ovarian cancer
- First Published: 03 May 2021

This manuscript demonstrated that PD-L1 promoted the angiogenesis and metastasis of ovarian cancer by participating in the c-JUN/VEGFR2 signaling axis, and suggested that the combination of PD-L1 inhibitor and antiangiogenic drugs may be considered as a potential therapeutic approach for ovarian cancer patients.
RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells
- First Published: 08 January 2021
Ovarian cancer-excreted exosomal miR-199a-5p suppresses tumor metastasis by targeting hypoxia-inducible factor-2α in hypoxia microenvironment
- First Published: 19 May 2020
Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China
- First Published: 15 July 2019